Construction and Characterization of an lpxM-Deficient Acinetobacter baumannii Strain Using a pyrF/5-FOA

Can Gao1, Kun Jiang1, Jiaxin Qi1

  • 1Department of Clinical Laboratory, Suining Central Hospital, Suining, Sichuan, People's Republic of China.

PubMed
Abstract

Insights

Deleting the lpxM gene significantly reduces the growth and enhances antibiotic susceptibility in multidrug-resistant Acinetobacter baumannii (MDR-AB). This finding offers a new target for combating MDR-AB infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Multidrug-resistant Acinetobacter baumannii (MDR-AB) poses a significant threat due to limited effective antibiotic options.
  • Lipopolysaccharide (LPS) biosynthesis, involving lysophospholipid acyltransferases (LPLATs) encoded by lpxM, is crucial for Gram-negative bacterial survival and drug resistance.

Purpose of the Study:

  • To investigate the impact of the lpxM gene on the growth and drug susceptibility of MDR-AB.
  • To explore lpxM as a potential target for novel antibacterial strategies against MDR-AB.

Main Methods:

  • Gene knockout of lpxM in Acinetobacter baumannii (AB) AYE using a pyrF/5-FOA-based counterselectable method.
  • Comparative analysis of growth rates (OD600) and minimum inhibitory concentrations (MICs) of the lpxM knockout strain against conventional antibiotics.

Main Results:

  • Successful and complete knockout of the lpxM gene was achieved.
  • The lpxM knockout strain exhibited a significantly reduced growth rate (OD600 ~2.5).
  • Antibiotic sensitivity was enhanced, with decreased MICs for imipenem (16 to 1 μg/mL) and ceftazidime (32 to 16 μg/mL).

Conclusions:

  • Deletion of the lpxM gene significantly alters the growth and drug resistance profiles of AB.
  • These findings provide a basis for understanding LPS-mediated drug resistance mechanisms.
  • Targeting lpxM presents a promising strategy for developing auxiliary inhibitors against MDR-AB.